Cargando…

Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data

To provide initial data on local SARS-CoV-2 epidemiology and spread in indigenous communities in north-eastern Colombia, respiratory swabs and serum samples from volunteers of indigenous communities were examined in March and April 2021. Samples from non-indigenous Colombians from the same villages...

Descripción completa

Detalles Bibliográficos
Autores principales: Concha, Gustavo, Frickmann, Hagen, Oey, Anke, Strengert, Monika, Kreienbrock, Lothar, Kann, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539650/
https://www.ncbi.nlm.nih.gov/pubmed/34696227
http://dx.doi.org/10.3390/vaccines9101120
_version_ 1784588798374445056
author Concha, Gustavo
Frickmann, Hagen
Oey, Anke
Strengert, Monika
Kreienbrock, Lothar
Kann, Simone
author_facet Concha, Gustavo
Frickmann, Hagen
Oey, Anke
Strengert, Monika
Kreienbrock, Lothar
Kann, Simone
author_sort Concha, Gustavo
collection PubMed
description To provide initial data on local SARS-CoV-2 epidemiology and spread in indigenous communities in north-eastern Colombia, respiratory swabs and serum samples from volunteers of indigenous communities were examined in March and April 2021. Samples from non-indigenous Colombians from the same villages were included as well. While previous exposure to SARS-CoV-2 was assessed by analysing serum samples for IgG and IgM with a rapid antibody point-of-care-test (POCT), screening for active infections was carried out with an antigen POCT test and real-time PCR from nasal swabs. In 380 indigenous and 72 non-indigenous volunteers, 61 (13.5%) active infections and an additional 113 (25%) previous infections were identified using diagnostic serology and molecular assays. Previous infections were more frequent in non-indigenous volunteers, and relevant associations of clinical features with active or previous SARS-CoV-2 infections were not observed. Symptoms reported were mild to moderate. SARS-CoV-2 was frequent in the assessed Colombian indigenous communities, as 38.5% of the study participants showed signs of exposure to SARS-CoV-2, which confirms the need to include these indigenous communities in screening and vaccination programs.
format Online
Article
Text
id pubmed-8539650
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85396502021-10-24 Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data Concha, Gustavo Frickmann, Hagen Oey, Anke Strengert, Monika Kreienbrock, Lothar Kann, Simone Vaccines (Basel) Article To provide initial data on local SARS-CoV-2 epidemiology and spread in indigenous communities in north-eastern Colombia, respiratory swabs and serum samples from volunteers of indigenous communities were examined in March and April 2021. Samples from non-indigenous Colombians from the same villages were included as well. While previous exposure to SARS-CoV-2 was assessed by analysing serum samples for IgG and IgM with a rapid antibody point-of-care-test (POCT), screening for active infections was carried out with an antigen POCT test and real-time PCR from nasal swabs. In 380 indigenous and 72 non-indigenous volunteers, 61 (13.5%) active infections and an additional 113 (25%) previous infections were identified using diagnostic serology and molecular assays. Previous infections were more frequent in non-indigenous volunteers, and relevant associations of clinical features with active or previous SARS-CoV-2 infections were not observed. Symptoms reported were mild to moderate. SARS-CoV-2 was frequent in the assessed Colombian indigenous communities, as 38.5% of the study participants showed signs of exposure to SARS-CoV-2, which confirms the need to include these indigenous communities in screening and vaccination programs. MDPI 2021-10-01 /pmc/articles/PMC8539650/ /pubmed/34696227 http://dx.doi.org/10.3390/vaccines9101120 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Concha, Gustavo
Frickmann, Hagen
Oey, Anke
Strengert, Monika
Kreienbrock, Lothar
Kann, Simone
Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data
title Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data
title_full Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data
title_fullStr Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data
title_full_unstemmed Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data
title_short Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data
title_sort direct and indirect proof of sars-cov-2 infections in indigenous wiwa communities in north-eastern colombia—a cross-sectional assessment providing preliminary surveillance data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539650/
https://www.ncbi.nlm.nih.gov/pubmed/34696227
http://dx.doi.org/10.3390/vaccines9101120
work_keys_str_mv AT conchagustavo directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata
AT frickmannhagen directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata
AT oeyanke directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata
AT strengertmonika directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata
AT kreienbrocklothar directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata
AT kannsimone directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata